{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Stephen+Doughty&max-ddpModified.=2021-02-03T13%3A19%3A58.618Z&answer.answeringMemberConstituency=Stratford-on-Avon®isteredInterest=false", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMember.label=Biography+information+for+Stephen+Doughty&max-ddpModified.=2021-02-03T13%3A19%3A58.618Z&answer.answeringMemberConstituency=Stratford-on-Avon®isteredInterest=false", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Stephen+Doughty&max-ddpModified.=2021-02-03T13%3A19%3A58.618Z&answer.answeringMemberConstituency=Stratford-on-Avon®isteredInterest=false&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Stephen+Doughty&_page=0&max-ddpModified.=2021-02-03T13%3A19%3A58.618Z&answer.answeringMemberConstituency=Stratford-on-Avon®isteredInterest=false", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Stephen+Doughty&max-ddpModified.=2021-02-03T13%3A19%3A58.618Z&answer.answeringMemberConstituency=Stratford-on-Avon®isteredInterest=false", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Stephen+Doughty&max-ddpModified.=2021-02-03T13%3A19%3A58.618Z&answer.answeringMemberConstituency=Stratford-on-Avon®isteredInterest=false", "items" : [{"_about" : "http://data.parliament.uk/resources/1281032", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1281032/answer", "answerText" : {"_value" : "

When fully operationally in 2022, the Vaccines Manufacturing and Innovation Centre (VMIC) will have several Good Manufacturing Process suites that will be able to accommodate a range of production scale capabilities. For pandemic response, the VMIC will be able to make up to 70 million doses of a vaccine within a 6-month timeframe. This is a significant increase to the VMIC\u2019s originally anticipated capacity.<\/p>

<\/p>

The VMIC has been designed to be a flexible manufacturing facility and will be able to manufacture a range of vaccine types, such as messenger RNA, viral vector, or protein sub-unit.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-02-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-01T16:13:48.117Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccine Manufacturing and Innovation Centre: Finance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 26 January 2021 to Question 141474, how many additional vaccine doses per month the expanded Vaccine Manufacturing Innovation Centre facility can produce as a result of the investment outlined in that Answer; and of which types of vaccine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4264", "label" : {"_value" : "Biography information for Stephen Doughty"} } , "tablingMemberConstituency" : {"_value" : "Cardiff South and Penarth"} , "tablingMemberPrinted" : [{"_value" : "Stephen Doughty"} ], "uin" : "144691"} , {"_about" : "http://data.parliament.uk/resources/1280122", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1280122/answer", "answerText" : {"_value" : "

The Vaccines Manufacturing and Innovation Centre (VMIC) should be partially open in summer 2021, with the facility fully operational in 2022. The VMIC is working towards having fill-finish capability at the end of 2021. The objective remains to accelerate the readiness of the VMIC by a year and it is on track to achieve this, but it is also important to remember this is a complex project being delivered in unprecedented times.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-01-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-01-28T17:21:34.833Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccine Manufacturing and Innovation Centre"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, when the expansion of the VMIC facility is planned to be completed.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4264", "label" : {"_value" : "Biography information for Stephen Doughty"} } , "tablingMemberConstituency" : {"_value" : "Cardiff South and Penarth"} , "tablingMemberPrinted" : [{"_value" : "Stephen Doughty"} ], "uin" : "142941"} , {"_about" : "http://data.parliament.uk/resources/1280124", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1280124/answer", "answerText" : {"_value" : "

The Government is currently undertaking its own laboratory work as a priority to better understand the impact of the new Covid-19 variants on the vaccines currently in deployment, in particular the risk of vaccine resistance. We maintain close contact with vaccine developers to understand their own studies as to the efficacy of their vaccines on variants and the impact on current supply chain arrangements for their manufacture.<\/p>

<\/p>

We continue to take a portfolio-based approach that monitors the landscape of Covid-19 vaccine development and we remain confident that the three vaccines (Pfizer/BioNTech, Oxford University/AstraZeneca, and Moderna) that we have purchased, which have been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA), will continue to be effective against the virus.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-01-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-01-28T17:19:44.303Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the (a) design, (b) bio-engineering and (c) manufacture of vaccines capable of responding to the 501 and 484 variants of covid-19 has commenced.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4264", "label" : {"_value" : "Biography information for Stephen Doughty"} } , "tablingMemberConstituency" : {"_value" : "Cardiff South and Penarth"} , "tablingMemberPrinted" : [{"_value" : "Stephen Doughty"} ], "uin" : "142942"} , {"_about" : "http://data.parliament.uk/resources/1280125", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1280125/answer", "answerText" : {"_value" : "

The Government is currently undertaking its own laboratory work as a priority to better understand the impact of the new Covid-19 variants on the vaccines currently in deployment, in particular the risk of vaccine resistance. We maintain close contact with vaccine developers to understand their own studies as to the efficacy of their vaccines on variants and the impact on current supply chain arrangements for their manufacture.<\/p>

<\/p>

We continue to take a portfolio-based approach that monitors the landscape of Covid-19 vaccine development and we remain confident that the three vaccines (Pfizer/BioNTech, Oxford University/AstraZeneca, and Moderna) that we have purchased, which have been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA), will continue to be effective against the virus.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-01-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-01-28T17:17:49.753Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, when vaccines capable of responding to the 501 and 484 variants of covid-19 will be available for use in the general population.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4264", "label" : {"_value" : "Biography information for Stephen Doughty"} } , "tablingMemberConstituency" : {"_value" : "Cardiff South and Penarth"} , "tablingMemberPrinted" : [{"_value" : "Stephen Doughty"} ], "uin" : "142943"} , {"_about" : "http://data.parliament.uk/resources/1279579", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1279579/answer", "answerText" : {"_value" : "

The Government has procured 40 million doses of the Pfizer/BioNTech and 100 million doses of the Oxford University/AstraZeneca vaccines.<\/p>

<\/p>

The UK was the first country in the world to start a vaccination programme using these vaccines. As of 26 January 2021, over 6.85 million people across the UK have been vaccinated with the first dose of the vaccine. We continue to work to meet our target of vaccinating all four priority groups by 15 February.<\/p>

<\/p>

Vaccines are a precious resource in very high demand across the world; therefore, for security reasons it is not possible to provide detail about the size of our supplies and exact detail about deliveries.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-01-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-01-27T17:19:30.99Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, how many doses of the (a) Pfizer-BioNTech and (b) Oxford-AstraZeneca vaccine are physically present in the UK and being held in storage, yet to be deployed or prepared for delivery.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4264", "label" : {"_value" : "Biography information for Stephen Doughty"} } , "tablingMemberConstituency" : {"_value" : "Cardiff South and Penarth"} , "tablingMemberPrinted" : [{"_value" : "Stephen Doughty"} ], "uin" : "141990"} , {"_about" : "http://data.parliament.uk/resources/1279585", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1279585/answer", "answerText" : {"_value" : "

Public Health England (PHE) secured 58 ultra-low temperature (ULT) freezers which provide sufficient storage for approximately five million doses of potential COVID-19 vaccines which require ULT storage. These ULT freezers were in place, commissioned and ready to receive vaccine prior to the commencement of the programme at the beginning of December 2020. The ULT freezers are for PHE to manage the national storage of COVID-19 vaccines which require storage at -70°C. The National Health Service has secured its own ULT freezers to support local storage.<\/p>

PQ141991<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-01-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-01-27T17:07:52.453Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-01-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many additional cold chain storage refrigerators capable of safely storing the Pfizer-BioNTech vaccine have been (a) ordered, (b) delivered and (c) deployed by the Government in each month since 1 September 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4264", "label" : {"_value" : "Biography information for Stephen Doughty"} } , "tablingMemberConstituency" : {"_value" : "Cardiff South and Penarth"} , "tablingMemberPrinted" : [{"_value" : "Stephen Doughty"} ], "uin" : "141991"} , {"_about" : "http://data.parliament.uk/resources/1279593", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1279593/answer", "answerText" : {"_value" : "

The Government has made several strategic investments in UK vaccine manufacturing capabilities to increase its capacity, ensuring we are able to manufacture across different vaccine technologies and embed resilience. This includes:<\/p>

<\/p>